2,579
Views
1
CrossRef citations to date
0
Altmetric
Research Article

In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin

, , , , , , , , , , , , & show all
Article: 2197177 | Received 12 Jan 2023, Accepted 26 Mar 2023, Published online: 20 Apr 2023

References

  • Aliberti C, Carandina R, Sarti D, et al. (2017). Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience. Future Oncol 13:1–8.
  • Alshabrawy AK, Bergamin A, Sharma DK, et al. (2021). LC-MS/MS analysis of vitamin D(3) metabolites in human serum using a salting-out based liquid-liquid extraction and DAPTAD derivatization. J Chromatogr B Analyt Technol Biomed Life Sci 1173:122654.
  • Ashrafi K, Tang Y, Britton H, et al. (2017). Characterization of a novel intrinsically radiopaque drug-eluting bead for image-guided therapy: DC Bead LUMITM. J Control Release 250:36–47.
  • Brown KT, Do RK, Gonen M, et al. (2016). Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J Clin Oncol 34:2046–53.
  • Chen Q, Shu L, Sun Y, et al. (2021). In vitro drug loading, releasing profiles, and in vivo embolic efficacy and safety evaluation of a novel drug-eluting microsphere (CalliSpheres). Cancer Biother Radiopharm. doi:10.1089/cbr.2020.3766.
  • de Baere T, Plotkin S, Yu R, et al. (2016). An in vitro evaluation of four types of drug-eluting microspheres loaded with doxorubicin. J Vasc Interv Radiol 27:1425–31.
  • Dreher MR, Sharma KV, Woods DL, et al. (2012). Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine. J Vasc Interv Radiol 23:257–64.e4.
  • Duran R, Sharma K, Dreher MR, et al. (2016). A novel inherently radiopaque bead for transarterial embolization to treat liver cancer – a pre-clinical study. Theranostics 6:28–39.
  • Garuti F, Neri A, Avanzato F, et al. (2021). The changing scenario of hepatocellular carcinoma in Italy: an update. Liver Int 41:585–97.
  • Granito A, Facciorusso A, Sacco R, et al. (2021). TRANS-TACE: prognostic role of the transient hypertransaminasemia after conventional chemoembolization for hepatocellular carcinoma. J Pers Med 11:1041.
  • Han X, Chen Q, Sun Y, et al. (2019). Morphology, loadability, and releasing profiles of callispheres microspheres in delivering oxaliplatin: an in vitro study. Technol Cancer Res Treat 18:1533033819877989.
  • He Y, Zhang Y, Gong Y, et al. (2022). Multimodal imaging of nano-assembled microspheres loaded with doxorubicin and Cisplatin for liver tumor therapy. Front Bioeng Biotechnol 10:1024174.
  • Johnson CG, Tang Y, Beck A, et al. (2016). Preparation of radiopaque drug-eluting beads for transcatheter chemoembolization. J Vasc Interv Radiol 27:117–26.e3.
  • Jordan O, Denys A, De Baere T, et al. (2010). Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol 21:1084–90.
  • Karalli A, Teiler J, Haji M, et al. (2019). Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting. Scand J Gastroenterol 54:905–12.
  • Kim DH, Li W, Chen J, et al. (2016). Multimodal imaging of nanocomposite microspheres for transcatheter intra-arterial drug delivery to liver tumors. Sci Rep 6:29653.
  • Lammer J, Malagari K, Vogl T, et al. (2010). Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52.
  • Lee EW, Khan S. (2017). Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma. Clin Mol Hepatol 23:265–72. Dec
  • Levy EB, Krishnasamy VP, Lewis AL, et al. (2016). First human experience with directly image-able iodinated embolization microbeads. Cardiovasc Intervent Radiol 39:1177–86.
  • Lewis AL, Willis SL, Dreher MR, et al. (2018). Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance. Future Oncol 14:2741–60.
  • Lu E, Tie J, Liu L, et al. (2021). An in vitro comparative study of three drug-eluting beads loaded with raltitrexed. Cancer Biother Radiopharm. doi:10.1089/cbr.2021.0251.
  • Mikhail AS, Mauda-Havakuk M, Negussie AH, et al. (2022). Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization. Int J Pharm 616:121466.
  • Mikhail AS, Pritchard WF, Negussie AH, et al. (2018). Mapping drug dose distribution on CT images following transarterial chemoembolization with radiopaque drug-eluting beads in a rabbit tumor model. Radiology 289:396–404.
  • Mikhail AS, Pritchard WF, Negussie AH, et al. (2022). Cone-beam computed tomography-based spatial prediction of drug dose after transarterial chemoembolization using radiopaque drug-eluting beads in woodchuck hepatocellular carcinoma. Invest Radiol 57:495–501.
  • Negussie AH, de Ruiter QMB, Britton H, et al. (2021). Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization. Sci Rep 11:533.
  • Negussie AH, Dreher MR, Johnson CG, et al. (2015). Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization. J Mater Sci Mater Med 26:198.
  • Negussie AH, Mikhail AS, Owen JW, et al. (2022). In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer. Sci Rep 12:21886.
  • Sakr OS, Berndt S, Carpentier G, et al. (2016). Arming embolic beads with anti-VEGF antibodies and controlling their release using LbL technology. J Controlled Release 224:199–207.
  • Shao G, Zou Y, Lucatelli P, et al. (2021). Chinese expert consensus on technical recommendations for the standard operation of drug-eluting beads for transvascular embolization. Ann Transl Med 9:714.
  • Sharma KV, Dreher MR, Tang Y, et al. (2010). Development of “imageable” beads for transcatheter embolotherapy. J Vasc Interv Radiol 21:865–76.
  • Su T, Huang S, Zhang Y, et al. (2022). miR-7/TGF-β2 axis sustains acidic tumor microenvironment-induced lung cancer metastasis. Acta Pharm Sin B 12:821–37.
  • Sung H, Ferlay J, Siegel RL, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–49.
  • van Elk M, Ozbakir B, Barten-Rijbroek AD, et al. (2015). Alginate microspheres containing temperature sensitive liposomes (TSL) for MR-guided embolization and triggered release of doxorubicin. PloS One 10:e0141626.
  • van Hooy-Corstjens CS, Saralidze K, Knetsch ML, et al. (2008). New intrinsically radiopaque hydrophilic microspheres for embolization: synthesis and characterization. Biomacromolecules 9:84–90.
  • Yuan TF, Le J, Wang ST, Li Y. (2020). An LC/MS/MS method for analyzing the steroid metabolome with high accuracy and from small serum samples. J Lipid Res 61:580–6.
  • Zhang S, Huang C, Li Z, et al. (2017). Comparison of pharmacokinetics and drug release in tissues after transarterial chemoembolization with doxorubicin using diverse lipiodol emulsions and CalliSpheres Beads in rabbit livers. Drug Deliv. 24:1011–17.